Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal... Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopists with excision of gastrointestinal lesions; Lumeblue, a diagnostic drug for the visualisation of colorectal lesions during colonoscopies; Aemcolo/Rifamycin, a pharmaceutical drug product in form of tablets that is approved for the treatment of travelers’ diarrhoea; and Clascoterone, which is in phase-3 clinical trial for the treatment of male pattern hair loss. It is also developing novel UC treatment, which is in phase-2 clinical trial for the treatment of distal inflammatory bowel disease/distal ulcerative colitis/proctitis; BAD Treatment (CB-01-33), which is in phase-2 clinical trial for the treatment of colesevelam formulation/bile acid diarrhea; and CB-03-10, which is in phase-1 clinical trial for the treatment of oncology solid tumors, as well as provides Cosmo’s AI technology, a GI Genius intelligent endoscopy system. The company was formerly known as Cosmo Pharmaceuticals N.V. and changed its name to Cosmo N.V. in April 2026. The company was founded in 1997 and is headquartered in Dublin, Ireland. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.538 | 0.613385018812 | 87.71 | 90 | 84.49 | 325 | 86.93856 | CS |
| 4 | -7.252 | -7.59371727749 | 95.5 | 107.8099 | 84.49 | 350 | 93.40040951 | CS |
| 12 | -13.002 | -12.8414814815 | 101.25 | 136.38 | 84.49 | 344 | 105.76029292 | CS |
| 26 | -37.752 | -29.9619047619 | 126 | 169.9 | 84.49 | 480 | 123.22967855 | CS |
| 52 | 10.368 | 13.312788906 | 77.88 | 169.9 | 75 | 624 | 121.88438988 | CS |
| 156 | 46.148 | 109.6152019 | 42.1 | 169.9 | 41.5 | 537 | 115.01606582 | CS |
| 260 | -7.752 | -8.075 | 96 | 169.9 | 41.5 | 517 | 112.48502457 | CS |
Kitfox
4分前
jara-mill
6分前
katiesdad7
7分前
ptk123
8分前
jara-mill
9分前
CommodityCoverage
9分前
gfp927z
14分前
OracleWitch66
15分前
MONTI KING
16分前
333randy
16分前
lucky, mydog
18分前
Dapper1
20分前
SSKILLZ1
20分前
SSKILLZ1
22分前
SSKILLZ1
23分前
Dapper1
24分前
stoxjock
24分前
KngmAz
25分前
rmoss
26分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。